During the past decade, Hopital Larrey; Pneumologie conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 7 clinical trials were completed, i.e. on average, 41.2% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 3 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hopital Larrey; Pneumologie" #1 sponsor was "Hoffmann-La Roche" with 13 trials, followed by "Intergroupe Francophone de Cancerologie Thoracique" with 10 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 2 trials sponsored, "Ariad Pharmaceuticals" with 1 trials sponsored and "Gilead Sciences" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Larrey; Pneumologie" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "ANRS, Emerging Infectious Diseases" with 1 trials as a collaborator, "Groupe Francais De Pneumo-Cancerologie" with 1 trials as a collaborator, "Takeda" with 1 trials as a collaborator and "University Hospital, Caen" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Hopital Larrey; Pneumologie" are "Carcinoma, Non-Small-Cell Lung" (4 trials), "Non-small Cell Lung Cancer" (4 trials), "Neoplasms" (3 trials), "Non-Small Cell Lung Cancer" (3 trials) and "Idiopathic Pulmonary Fibrosis" (2 trials). Many other conditions were trialed in "Hopital Larrey; Pneumologie" in a lesser frequency.

Most popular intervention types in "Hopital Larrey; Pneumologie" are "Drug" (26 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (6 trials), "Pemetrexed" (5 trials), "Alectinib" (4 trials), "Docetaxel" (4 trials) and "Carboplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Larrey; Pneumologie" are 27 trials for "All" genders.

Currently, there are NaN active trials in "Hopital Larrey; Pneumologie". undefined are not yet recruiting, 9 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Hopital Larrey; Pneumologie, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Larrey; Pneumologie, 0 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".